Frontiers in Pharmacology

Tirzepatide versus other anti-diabetic agents for the prevention of diabetic foot complications in patients with type 2 diabetes

By Chia-Yu Kuo, Jheng-Yan Wu, Ya-Wen Tsai, Chih-Cheng Lai, Jiun-Ling Wang

Study in peopleInterventions

The paper

Chia-Yu Kuo, Jheng-Yan Wu, Ya-Wen Tsai, Chih-Cheng Lai, Jiun-Ling Wang

Chi Mei Medical Center; National Cheng Kung University Hospital

Frontiers in Pharmacology, 24 Sep 2026

doi.org/10.3389/fphar.2026.1880132 PubMed 42851503

Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Diabetes, Obesity & Metabolism8 Oct 2026
Diabetes drug class linked to slightly less frailty progression
Drug Design, Development and Therapy5 Oct 2026
GLP-1 agonists linked to lower dementia risk after COVID-19